...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Apabetalone’s Positive Impact on Pulmonary Arterial Hypertension Published in the American Journal of Respiratory and Critical Care Medicine

"The share price is terrible, no question there!"

 well that's the question/bottom line/answer after 20 years..."not to bad" eh

I'd much rather stay on the positive side, which I've been trying to do as of late but I can't disagree enough that "it's not too bad" or that people somehow think Don has been the saving grace all this time. 

All one has to do is listen to Don's forward looking statements over the last years & add up how many of them came true & how many didn't? And thats not counting all the "babble" behind the scenes thats been spewed.

 just another piece to the answer.

 

Sure successful covid trial , maybe take a few dollars off the table - keep some for BOM 2 success, sell out for billions, everyone walks or runs away happy & forgiving but i for one will never forget this .... show & the out right misleading forward looking statements.

 

 

 

 

Share
New Message
Please login to post a reply